Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1565-1581
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
A large-scale genome-wide cross-trait analysis reveals shared genetic architecture between Alzheimer’s disease and gastrointestinal tract disorders
Emmanuel O Adewuyi, Eleanor K. O’Brien, Dale R. Nyholt, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 69
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Anne‐Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3895-3895
Open Access | Times Cited: 50
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes
О. В. Долотов, Л. С. Иноземцева, N. F. Myasoedov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4999-4999
Open Access | Times Cited: 55
Therapeutic Potential of Experimental Stereotactic Hippocampal Cell Transplant in the Management of Alzheimer’s Disease
Loredana Mariana Agavriloaei, B. Iliescu, Robert Mihai Pintilie, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 891-891
Open Access
Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer’s disease-like pathology
Suélen Santos Alves, Gabriel Servilha‐Menezes, Letícia Rossi, et al.
Journal of Neural Transmission (2025)
Closed Access
Synthesis, Pharmacological Evaluation, and Molecular Modeling of Phthalimide Derivatives as Monoamine Oxidase and Cholinesterase Dual Inhibitors
Nabiha Abdullah, Fahad Hussain, Naseem Ullah, et al.
ACS Omega (2025)
Open Access
On the relationships between epilepsy, sleep, and Alzheimer’s disease: A narrative review
Julie M. Hanke, Kaspar Schindler, Andrea Seiler
Epilepsy & Behavior (2022) Vol. 129, pp. 108609-108609
Open Access | Times Cited: 19
Clinical evidence of human pathogens implicated in Alzheimer’s disease pathology and the therapeutic efficacy of antimicrobials: an overview
Celso S. G. Catumbela, Vijayasree V. Giridharan, Tatiana Barichello, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact
Javier Olazarán, Cristóbal Carnero Pardo, Juan Fortea, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Etiology and management of Alzheimer’s disease: Potential role of gut microbiota modulation with probiotics supplementation
Vaishali Dasriya, Mrinal Samtiya, Tejpal Dhewa, et al.
Journal of Food Biochemistry (2021) Vol. 46, Iss. 1
Open Access | Times Cited: 21
Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum
Natàlia Vilor‐Tejedor, Patricia Genius, Blanca Rodríguez‐Fernández, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 3, pp. 1703-1715
Open Access | Times Cited: 8
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 2
Five Major Psychiatric Disorders and Alzheimer’s Disease: A Bidirectional Mendelian Randomization Study
Tao Wei, Zheng Guo, Zhibin Wang, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 2, pp. 675-684
Closed Access | Times Cited: 11
Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease
Natalie Stahr, Elena Galkina
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Diagnostic groups of hospital stays and outpatient visits during 10 years before Alzheimer’s disease
Kiira Mäklin, Pasi Lampela, Julian Lin, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Brain Targeting of Citicoline Sodium via Hyaluronic Acid-Decorated Novel Nano-Transbilosomes for Mitigation of Alzheimer’s Disease in a Rat Model: Formulation, Optimization, in vitro and in vivo Assessment
Kariman M. AbouElhassan, Hatem A. Sarhan, Amal K. Hussein, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6347-6376
Open Access | Times Cited: 9
Muscarinic Receptors and Alzheimer’s Disease: New Perspectives and Mechanisms
Martina Monaco, Hanna Trebesova, Massimo Grilli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6820-6835
Open Access | Times Cited: 1
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion
Federico Menegon, Fabiola De Marchi, Davide Aprile, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1675-1675
Open Access | Times Cited: 1
Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance
Tapan Behl, Ashishkumar Kyada, R Roopashree, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102556-102556
Closed Access | Times Cited: 1
Alzheimer`s disease mortality in the United States: Cross-sectional analysis of county-level socio-environmental factors
Pedro Rafael Vieira de Oliveira Salerno, Weichuan Dong, Issam Motairek, et al.
Archives of Gerontology and Geriatrics (2023) Vol. 115, pp. 105121-105121
Closed Access | Times Cited: 4
Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
Karolina Maciejewska, Kamila Czarnecka, Paweł Kręcisz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5876-5876
Open Access | Times Cited: 7
A nomogram for predicting risk of death during hospitalization in elderly patients with Alzheimer's disease at the time of admission
Kecheng Yao, Junpeng Wang, Baohua Ma, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
A FinnGen pilot clinical recall study for Alzheimer’s disease
Valtteri Julkunen, Claudia Schwarz, Juho Kalapudas, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top